Estradiol Patch, Extended Release
Product Images NDC 69238-1295

Product Visual Gallery

This gallery contains 23 technical images submitted to the FDA as part of the official labeling for Estradiol (NDC 69238-1295). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (Estradiol Transdermal System Minivelle 1)

Chemical structure diagram of Estradiol, displaying its molecular rings and functional groups including hydroxyl (OH) and methyl (CH3) groups.*

FDA Label Image

Figure D (Estradiol Transdermal System Minivelle 10)

An instructional illustration depicting two hands peeling apart the protective liners of a transdermal patch, demonstrating the preparation step before application.*

FDA Label Image

Figure E (Estradiol Transdermal System Minivelle 11)

An instructional line drawing showing a person applying a transdermal patch to the lower abdominal area, just above the pubic region, demonstrating the proper placement technique for a patch such as an estradiol transdermal system.*

FDA Label Image

Figure F (Estradiol Transdermal System Minivelle 12)

Illustration showing the application of a transdermal patch on the lower abdomen of a person. The image depicts placement of a circular patch to the skin area below the navel, consistent with instructions for a transdermal estradiol patch.*

FDA Label Image

Figure G (Estradiol Transdermal System Minivelle 13)

Black and white instructional illustration showing hands applying a rectangular transdermal patch to the skin. The image demonstrates placement or usage of a medication patch, consistent with a topical extended-release delivery system.*

FDA Label Image

0.025 mg/day Pouch (Estradiol Transdermal System Minivelle 14)

Label for Estradiol Transdermal System, USP 0.025 mg/day patch by Amneal Pharmaceuticals LLC. The label details that one 1.89 cm² system contains 0.314 mg estradiol, USP, lists inactive components, storage instructions, and distributor information. It includes a barcode and highlights the 0.025 mg/day dosage strength.*

FDA Label Image

0.025 mg/day Carton (Estradiol Transdermal System Minivelle 15)

Packaging label for Estradiol Transdermal System, USP 0.025 mg/day patch. The box shows the product name, strength, dosage form as transdermal extended release, and directions stating twice weekly application. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label includes space for lot and expiration dates and a barcode. The design features purple accent bars with delivery and usage information.*

FDA Label Image

0.0375 mg/day Pouch (Estradiol Transdermal System Minivelle 16)

Label for Estradiol Transdermal System, USP patch delivering 0.0375 mg/day. The label states contents of one 2.83 cm² system containing 0.470 mg estradiol and lists inactive components. It includes storage instructions and distributor information for Amneal Pharmaceuticals LLC, Bridgewater, NJ. The label features a barcode and Amneal logo.*

FDA Label Image

0.0375mg Pouch (Estradiol Transdermal System Minivelle 17)

The image shows the packaging label for Estradiol Transdermal System, USP 0.0375 mg/day patch by Amneal Pharmaceuticals NY LLC. The label states it delivers 0.0375 mg/day and is applied twice weekly. It includes an application schedule, storage instructions, and a barcode. The label also has the Amneal logo and website information, and it notes that the package contains 8 systems (patches).*

FDA Label Image

0.0375 mg/day Carton (Estradiol Transdermal System Minivelle 18)

Label for Estradiol Transdermal System, USP delivering 0.05 mg/day in a single 3.78 cm² patch. Contains 0.627 mg of estradiol per system. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Lists inactive components and storage instructions, including temperature range. Includes barcode and Amneal logo.*

FDA Label Image

0.05 mg/day Pouch (Estradiol Transdermal System Minivelle 19)

The image shows packaging for Estradiol Transdermal System, USP, delivering 0.05 mg/day. It is a transdermal patch labeled by Amneal Pharmaceuticals LLC. The carton displays dosing and administration instructions to apply twice weekly and includes an application schedule checklist. The label also notes the package contains 8 systems and emphasizes Rx only use with the Amneal logo visible.*

FDA Label Image

3 Layers (Estradiol Transdermal System Minivelle 2)

An illustration diagram showing the layered construction of an estradiol transdermal extended release patch. The diagram labels three distinct layers: backing, adhesive containing estradiol, and protective liner as identified by different shading patterns and line styles.*

FDA Label Image

0.05 mg/day Carton (Estradiol Transdermal System Minivelle 20)

Label for Estradiol Transdermal System, USP delivering 0.075 mg/day. The label notes each 5.66 cm² system contains 0.940 mg of estradiol and includes a list of inactive components. The product is distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Storage instructions and a barcode are also visible.*

FDA Label Image

0.075 mg/day Pouch (Estradiol Transdermal System Minivelle 21)

Packaging label for Estradiol Transdermal System, USP, 0.075 mg/day, a transdermal patch by Amneal Pharmaceuticals NY LLC. The label includes dosage strength, dosing schedule options, storage instructions, usage warnings, and barcodes. It also notes the product delivers 0.075 mg/day and is for prescription use only.*

FDA Label Image

0.075 mg/day Carton (Estradiol Transdermal System Minivelle 22)

Label for Estradiol Transdermal System delivering 0.1 mg/day, a prescription extended-release patch. Contains one 7.55 cm² system with 1.253 mg estradiol. Lists inactive ingredients and storage instructions. Distributed by Amneal Pharmaceuticals LLC, Bridgewater, NJ. Includes NDC 69238-1296-1 and Amneal logo.*

FDA Label Image

0.1 mg/day Pouch (Estradiol Transdermal System Minivelle 23)

Estradiol Transdermal System, USP 0.1 mg/day extended-release patch packaging label distributed by Amneal Pharmaceuticals LLC. The label includes dosage instructions, warning statements, and a schedule to track patch application days. It notes delivery of 0.1 mg of estradiol per day with a package containing 8 systems. The labeler web address amneal.com is included.*

FDA Label Image

Figure 1 (Estradiol Transdermal System Minivelle 3)

A line graph depicting serum concentration (pg/mL) over time (days) for three different doses of estradiol patches: 0.1 mg per day, 0.05 mg per day, and 0.025 mg per day. Serum concentration increases rapidly after patch application, peaks between 0.5 and 1.5 days, and then declines toward baseline by day 5 for all three doses.*

FDA Label Image

Figure 2 (Estradiol Transdermal System Minivelle 4)

A bar graph comparing mean (SD) reduction from baseline at weeks 4, 8, and 12 between Vivelle 0.0375 mg/day and placebo groups. The vertical axis shows reduction values, with Vivelle bars consistently demonstrating greater reductions than placebo across all time points. Sample sizes for each group at each time point are annotated above bars.*

FDA Label Image

Figure 3 (Estradiol Transdermal System Minivelle 5)

A line graph depicting percent change from baseline over treatment duration in weeks (26, 52, 78, 104). It compares multiple dosages of a product labeled Vivelle at 0.1 mg/day, 0.05 mg/day, 0.0375 mg/day, and 0.025 mg/day versus placebo. Each line corresponds to a different dosage or placebo group, showing trends over time.*

FDA Label Image

Figure 4 (Estradiol Transdermal System Minivelle 6)

A line graph showing percentage change from baseline over treatment duration at weeks 26, 52, 78, and 104. It compares five groups: Vivelle 0.1 mg/day, Vivelle 0.05 mg/day, Vivelle 0.0375 mg/day, Vivelle 0.025 mg/day, and placebo. Statistical significance is indicated for several comparisons between groups versus placebo.*

FDA Label Image

Figure A (Estradiol Transdermal System Minivelle 7)

Packaging components for Estradiol Transdermal System, USP 0.025 mg/day from Amneal Pharmaceuticals NY LLC, including a carton labeled with the product name and strength, a calendar for tracking dose application, a pouch containing the patch, and a package insert/patient product information leaflet.*

FDA Label Image

Figure B (Estradiol Transdermal System Minivelle 8)

An instructional illustration for the Estradiol Transdermal System showing a hand holding a pen and marking a twice-weekly application schedule on a printed calendar inside an open medication carton. The text instructs users to read patient information and apply the patch as directed, emphasizing schedule tracking.*

FDA Label Image

Figure C (Estradiol Transdermal System Minivelle 9)

An instructional illustration showing hands opening a foil pouch labeled Estradiol Transdermal System, USP 0.05 mg/day. The image demonstrates the correct method of tearing open the pouch to access the transdermal patch inside.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.